AKRO
Price
$41.95
Change
+$3.31 (+8.57%)
Updated
Apr 2, 04:59 PM (EDT)
Capitalization
3.08B
48 days until earnings call
NERV
Price
$1.61
Change
+$0.06 (+3.87%)
Updated
Apr 2, 04:59 PM (EDT)
Capitalization
10.84M
41 days until earnings call
Ad is loading...

AKRO vs NERV

Header iconAKRO vs NERV Comparison
Open Charts AKRO vs NERVBanner chart's image
Akero Therapeutics
Price$41.95
Change+$3.31 (+8.57%)
Volume$46.45K
Capitalization3.08B
Minerva Neurosciences
Price$1.61
Change+$0.06 (+3.87%)
VolumeN/A
Capitalization10.84M
AKRO vs NERV Comparison Chart
Loading...
AKRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NERV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AKRO vs. NERV commentary
Apr 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AKRO is a StrongBuy and NERV is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 02, 2025
Stock price -- (AKRO: $38.64 vs. NERV: $1.55)
Brand notoriety: AKRO and NERV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AKRO: 120% vs. NERV: 169%
Market capitalization -- AKRO: $3.08B vs. NERV: $10.84M
AKRO [@Biotechnology] is valued at $3.08B. NERV’s [@Biotechnology] market capitalization is $10.84M. The market cap for tickers in the [@Biotechnology] industry ranges from $302.51B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AKRO’s FA Score shows that 0 FA rating(s) are green whileNERV’s FA Score has 0 green FA rating(s).

  • AKRO’s FA Score: 0 green, 5 red.
  • NERV’s FA Score: 0 green, 5 red.
According to our system of comparison, NERV is a better buy in the long-term than AKRO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AKRO’s TA Score shows that 4 TA indicator(s) are bullish while NERV’s TA Score has 3 bullish TA indicator(s).

  • AKRO’s TA Score: 4 bullish, 5 bearish.
  • NERV’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, AKRO is a better buy in the short-term than NERV.

Price Growth

AKRO (@Biotechnology) experienced а -14.59% price change this week, while NERV (@Biotechnology) price change was -16.22% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.27%. For the same industry, the average monthly price growth was -7.37%, and the average quarterly price growth was -12.08%.

Reported Earning Dates

AKRO is expected to report earnings on May 20, 2025.

NERV is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (-5.27% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AKRO($3.08B) has a higher market cap than NERV($10.8M). AKRO YTD gains are higher at: 38.893 vs. NERV (-30.235). NERV has higher annual earnings (EBITDA): 6.02M vs. AKRO (-247.37M). AKRO has more cash in the bank: 743M vs. NERV (21.4M). NERV has less debt than AKRO: NERV (0) vs AKRO (36.5M). AKRO (0) and NERV (0) have equivalent revenues.
AKRONERVAKRO / NERV
Capitalization3.08B10.8M28,491%
EBITDA-247.37M6.02M-4,106%
Gain YTD38.893-30.235-129%
P/E RatioN/A8.95-
Revenue00-
Total Cash743M21.4M3,472%
Total Debt36.5M0-
FUNDAMENTALS RATINGS
NERV: Fundamental Ratings
NERV
OUTLOOK RATING
1..100
4
VALUATION
overvalued / fair valued / undervalued
1..100
57
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
49
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AKRONERV
RSI
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
88%
Momentum
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 22 days ago
83%
Bullish Trend 10 days ago
77%
Declines
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
85%
View a ticker or compare two or three
Ad is loading...
AKRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NERV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CGC1.020.11
+12.09%
Canopy Growth Corp
L92.090.18
+0.20%
Loews Corp
QDEL34.11-0.86
-2.46%
QuidelOrtho Corp
NAK1.11-0.04
-3.48%
Northern Dynasty Minerals Ltd
CANF1.40-0.08
-5.41%
Can-Fite BioPharma Ltd

NERV and

Correlation & Price change

A.I.dvisor indicates that over the last year, NERV has been loosely correlated with CVAC. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if NERV jumps, then CVAC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NERV
1D Price
Change %
NERV100%
-8.83%
CVAC - NERV
35%
Loosely correlated
-1.81%
SYRE - NERV
35%
Loosely correlated
-5.21%
DNLI - NERV
34%
Loosely correlated
-9.60%
AKRO - NERV
33%
Poorly correlated
-4.55%
ANAB - NERV
30%
Poorly correlated
-1.02%
More